BPC-157 is not approved by Health Canada or the FDA for human use
Subacute and chronic injuries predominantly feature demyelination of the nervous system and megaloblastic anemia, with up to 96% of patients experiencing neurological damage ( Spinal Cord Lesions: Symptoms include gait instability, sensory deficits, and motor weakness, often progressing to paraplegia in severe cases (Winstock and Ferris, 2020)
L.SaingP.HartP
10.1007/s10549-018-4753-7 36 FraserJ
O-Acetyl (N,N-dimethyl-D6 98%)-L-Carnitine HCl salt CAS number: 2692624-01-2 Identifiers CAS Index Name: 1-Propanaminium, 2-(acetyloxy)-3-carboxy-N-methyl-N,N-di(methyl-d3)-, inner salt, hydrochloride (1:1), (2R)- Molecular formula: C 9 H 11 D 6 NO 4 .ClH Molecular weight: 245.73 Smiles: Cl.O=C(OC(CC(=O)[O-])C[N+](C)(C)C)C Isomeric Smiles: C(C(CC([O-])=O)OC(C)=O)[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C.Cl InChI: InChI=1S/C9H17NO4.ClH/c1-7(11)14-8(5-9(12)13)6-10(2,3)4;/h8H,5-6H2,1-4H3;1H/t8-;/m1./s1/i2D3,3D3